UniProt ID | GEMI2_HUMAN | |
---|---|---|
UniProt AC | O14893 | |
Protein Name | Gem-associated protein 2 | |
Gene Name | GEMIN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 280 | |
Subcellular Localization | Nucleus, gem. Cytoplasm. Localized in subnuclear structures next to coiled bodies, called gems, which are highly enriched in spliceosomal snRNPs. Also found in the cytoplasm. | |
Protein Description | The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus.. | |
Protein Sequence | MRRAELAGLKTMAWVPAESAVEELMPRLLPVEPCDLTEGFDPSVPPRTPQEYLRRVQIEAAQCPDVVVAQIDPKKLKRKQSVNISLSGCQPAPEGYSPTLQWQQQQVAQFSTVRQNVNKHRSHWKSQQLDSNVTMPKSEDEEGWKKFCLGEKLCADGAVGPATNESPGIDYVQIGFPPLLSIVSRMNQATVTSVLEYLSNWFGERDFTPELGRWLYALLACLEKPLLPEAHSLIRQLARRCSEVRLLVDSKDDERVPALNLLICLVSRYFDQRDLADEPS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | AELAGLKTMAWVPAE HHHCCCCEEEEEEHH | 19.71 | 29255136 | |
19 | Phosphorylation | MAWVPAESAVEELMP EEEEEHHHHHHHHHH | 39.46 | 24719451 | |
34 | Glutathionylation | RLLPVEPCDLTEGFD HHCCCCCCCCCCCCC | 4.19 | 22555962 | |
37 | Phosphorylation | PVEPCDLTEGFDPSV CCCCCCCCCCCCCCC | 22.32 | 22210691 | |
43 | Phosphorylation | LTEGFDPSVPPRTPQ CCCCCCCCCCCCCHH | 49.45 | 22210691 | |
48 | Phosphorylation | DPSVPPRTPQEYLRR CCCCCCCCHHHHHHH | 34.79 | 25159151 | |
52 | Phosphorylation | PPRTPQEYLRRVQIE CCCCHHHHHHHHHHH | 10.56 | 29978859 | |
54 | Methylation | RTPQEYLRRVQIEAA CCHHHHHHHHHHHHH | 35.50 | 115916985 | |
63 | Glutathionylation | VQIEAAQCPDVVVAQ HHHHHHHCCCEEEEE | 2.39 | 22555962 | |
74 | Ubiquitination | VVAQIDPKKLKRKQS EEEECCHHHCCCCCC | 67.97 | 29967540 | |
75 | Ubiquitination | VAQIDPKKLKRKQSV EEECCHHHCCCCCCE | 65.71 | - | |
81 | Phosphorylation | KKLKRKQSVNISLSG HHCCCCCCEEEEECC | 21.84 | 28450419 | |
85 | Phosphorylation | RKQSVNISLSGCQPA CCCCEEEEECCCCCC | 15.98 | 28450419 | |
87 | Phosphorylation | QSVNISLSGCQPAPE CCEEEEECCCCCCCC | 30.63 | 28450419 | |
96 | Phosphorylation | CQPAPEGYSPTLQWQ CCCCCCCCCCCHHHH | 15.15 | 28450419 | |
97 | Phosphorylation | QPAPEGYSPTLQWQQ CCCCCCCCCCHHHHH | 23.43 | 28450419 | |
99 | Phosphorylation | APEGYSPTLQWQQQQ CCCCCCCCHHHHHHH | 26.16 | 28450419 | |
125 | Ubiquitination | NKHRSHWKSQQLDSN HHCHHHHHHHCCCCC | 32.72 | 29967540 | |
125 | Methylation | NKHRSHWKSQQLDSN HHCHHHHHHHCCCCC | 32.72 | 115981197 | |
131 | Phosphorylation | WKSQQLDSNVTMPKS HHHHCCCCCCCCCCC | 41.62 | 20068231 | |
145 | Acetylation | SEDEEGWKKFCLGEK CCCCCHHHHHHHCCC | 46.99 | 26051181 | |
145 | Ubiquitination | SEDEEGWKKFCLGEK CCCCCHHHHHHHCCC | 46.99 | - | |
146 | Ubiquitination | EDEEGWKKFCLGEKL CCCCHHHHHHHCCCC | 34.50 | - | |
163 | Phosphorylation | DGAVGPATNESPGID CCCCCCCCCCCCCCC | 42.52 | 24732914 | |
166 | Phosphorylation | VGPATNESPGIDYVQ CCCCCCCCCCCCEEE | 30.42 | 28348404 | |
171 | Phosphorylation | NESPGIDYVQIGFPP CCCCCCCEEEECCHH | 7.73 | 28464451 | |
197 | Phosphorylation | TVTSVLEYLSNWFGE HHHHHHHHHHHHHCC | 15.98 | 30257219 | |
199 | Phosphorylation | TSVLEYLSNWFGERD HHHHHHHHHHHCCCC | 30.98 | 30257219 | |
208 | Phosphorylation | WFGERDFTPELGRWL HHCCCCCCHHHHHHH | 21.83 | 30257219 | |
280 | Phosphorylation | RDLADEPS------- HHHCCCCC------- | 51.29 | 23312004 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GEMI2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GEMI2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GEMI2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RAD50_HUMAN | RAD50 | physical | 20403813 | |
RSMN_HUMAN | SNRPN | physical | 18984161 | |
GEMI5_HUMAN | GEMIN5 | physical | 23221635 | |
DDX20_HUMAN | DDX20 | physical | 23221635 | |
GEMI4_HUMAN | GEMIN4 | physical | 23221635 | |
GEMI8_HUMAN | GEMIN8 | physical | 23221635 | |
GEMI6_HUMAN | GEMIN6 | physical | 23221635 | |
GEMI7_HUMAN | GEMIN7 | physical | 23221635 | |
STRAP_HUMAN | STRAP | physical | 23221635 | |
SMN_HUMAN | SMN1 | physical | 23221635 | |
STRN4_HUMAN | STRN4 | physical | 28514442 | |
RU17_HUMAN | SNRNP70 | physical | 28514442 | |
GEMI4_HUMAN | GEMIN4 | physical | 28514442 | |
GEMI7_HUMAN | GEMIN7 | physical | 28514442 | |
ACTA_HUMAN | ACTA2 | physical | 28514442 | |
SMD1_HUMAN | SNRPD1 | physical | 28514442 | |
ACTBL_HUMAN | ACTBL2 | physical | 28514442 | |
NUFP1_HUMAN | NUFIP1 | physical | 26275778 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-48, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-171, AND MASSSPECTROMETRY. |